PubMed Health⌕ Search

PubMed · 10435521

Virtual light field projection for CT-simulation.

Abstract

We report a method to project a virtual light field over the patient during CT-simulations of external beam radiotherapy. It can be used to perform all the tasks associated with the physical light field of a conventional simulator. The system consists of a three-dimensional sonic digitizer interfacing with a window-based software on a personal computer. The digitizer can provide the three-dimensional coordinates of any point in space accessible by the digitizer probe. When these coordinates are transformed into the beam's eye view, the position of the digitized point relative to the beam can readily be displayed. Thus, the system establishes a virtual light field in space, which can be "seen" only by the digitizer probe. For any digitized point, the system can immediately show, by the beam's eye view display, whether the point is inside the field, outside of the field, or on the field border. Moreover, this virtual field projection allows one to evaluate external target coverage (or external normal tissue sparing) conveniently and interactively. By simply digitizing the concerned area and viewing its position in the beam's eye view display, one can immediately assess the coverage and if necessary, modify the treatment field accordingly. The system also provides an efficient and essential procedure in CT-simulations for marking treatment portals on the patient. By cruising the digitizer probe on the patient's skin surface under visual and audio guidances, one can promptly find the projection of the field center, field corners, etc., on the patient. Measurements have been performed to study the accuracy of the GP-12 sonic digitizer using rigid phantoms. Based on the measured data, the overall accuracy of the portal localization system is estimated to be +/-2 mm. The system has been in clinical use for our CT simulator.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

H M Lu, L Chin. 1999. Virtual light field projection for CT-simulation.. https://doi.org/10.1118/1.598616

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Model-based estimation of myeloid hematopoietic progenitor cells in ex vivo cultures for cell and gene therapies.

Ex vivo production of hematopoietic progenitor cells has potential applications for cell therapy to alleviate cytopenias associated with chemotherapy and for gene therapy. In both therapies, progenitor and stem cells are considered crucial factors for therapeutic success. Assays for progenitor cells, however, take 2 weeks to complete, which is similar to the length of a typical culture. Therefore, a real-time estimation of the percentage or number of progenitor cells, based on rapid measurements, would be useful for optimization of feeding and harvest decisions. In this study, metabolic activity assays and flow cytometric analysis were used to estimate the content of progenitor cells. The measured metabolic activities are a collective contribution from all types of cells. Cells in granulomonocytic cultures have been lumped into six cell types and metabolic rates have been modeled as a linear function of cell composition and growth rate and as a nonlinear function of cell density. Data from 24 experiments were utilized to determine the model parameters in a calibration step. These data include flow cytometric analysis of more mature hematopoietic cells, progenitor cell colony assays, total cell content, and metabolite concentrations, and cover a wide range of cell composition, cell density, and growth rate. After calibration, the model is able to deliver good predictions of progenitor cell content for cultures with higher percentages of progenitor cells, as well as the peak progenitor cell content, based only on parameters that can be rapidly measured. With the aid of those predictions a harvest strategy was developed that will allow optimizing the harvest time based on the culture kinetics of each patient or donor inoculum, rather than using retrospective analysis to determine a uniform harvest time.

Calibration↗

Radioassays and experimental evaluation of dose calibrator settings for 18F.

The positron emitter 18F continues to be one of the most important imaging radionuclides in diagnostic nuclear medicine. Assays of radiopharmaceuticals containing this nuclide are often performed in the clinic using commercial reentrant ionization chambers, or "dose calibrators". Meaningful quantitative clinical studies require accurate knowledge of the injected activity which requires proper calibration of these instruments. Radioassays were performed at the National Institute of Standards and Technology (NIST) on a solution of 18F produced at the National Institutes of Health (NIH) using 4pibeta liquid scintillation (fS) counting with 3H-standard efficiency tracing. Cocktails containing water fractions of approximately 0.9 and 9% (both as saline) were used. The massic activity values were measured to be 2.52+/-0.06 and 2.50+/-0.03 MBq g(-1), respectively, for the 0.9 and 9% water cocktails as of the reference time. The uncertainties on the activity measurements are expanded (k = 2) uncertainties. The largest uncertainty component was found to be the repeatability on a single LS source, with the cocktails containing 0.9% water fraction exhibiting a larger variability by nearly a factor of two. Reproducibility between LS cocktails with the same water fraction was also found to be a large uncertainty component, but with a value less than half that due to measurement repeatability. Radionuclidic impurities consisted of 48V and 46Sc, at levels of 0.11+/-0.08% (expanded uncertainties) and approximately 2 x 10(-3)% (upper limit) relative to the activity of the 18F, as of the reference time. Dose calibrator dial settings for measuring solutions of 18F were experimentally determined for Capintec CRC-12 and CRC-35R dose calibrators in three measurement geometries: a 5-ml standard NIST ampoule (two ampoules measured), a 12-ml plastic syringe containing 9 ml of solution and a 10-ml Mallinckrodt molded dose vial filled with 5 ml of solution. The experimental dial settings (and the corresponding expanded uncertainties) for these geometries were found to be 477+/-7, 474+/-6, 482+/-6 and 463+/-7 for the two ampoules, the syringe and the dose vial, respectively, in the CRC-12. The dial settings determined for the CRC-35R were 472+/-7, 470+/-7, 464+/-6 and 456+/-6 for the two ampoules, the syringe, and the dose vial, respectively. The uncertainties in the dial settings are expanded uncertainties. Comparisons between the empirically determined dial settings and the manufacturer's recommended setting of "439" indicate that use of the manufacturer's setting overestimates the activity by between 3 and 6%, depending upon the geometry used.

Calibration↗